新药开发-话题@MedSci

#新药开发#

14篇内容 | 1310人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2091679, encodeId=d80a20916e9c0, content=<a href='/topic/show?id=fd3a1018623d' target=_blank style='color:#2F92EE;'>#骨质疏松#</a><a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a><a href='/topic/show?id=60c3434046f' target=_blank style='color:#2F92EE;'>#多肽药物#</a>, objectTitle=Cell子刊：既能促骨形成又能抑骨吸收，研究发现抗骨质疏松药物新靶标！, objectType=article, longId=260902, objectId=1d1c260902f4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202201003/1664769551788_8252897.jpeg, objectUrl=/article/show_article.do?id=1d1c260902f4, replyNumber=0, likeNumber=155, createdTime=2022-10-04, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d1c260902f4, moduleTitle=Cell子刊：既能促骨形成又能抑骨吸收，研究发现抗骨质疏松药物新靶标！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d1c260902f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655598, encodeId=ee1c1655598ef, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=专注改良新药开发！清普生物成功获得近5000万元pre-A轮融资, objectType=article, longId=200688, objectId=6ba62006881a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba62006881a, replyNumber=0, likeNumber=92, createdTime=2020-09-17, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba62006881a, moduleTitle=专注改良新药开发！清普生物成功获得近5000万元pre-A轮融资, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ba62006881a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655597, encodeId=5e36165559e35, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=移植物抗宿主病（GVHD）新药开发攻略, objectType=article, longId=200195, objectId=647b2001953f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=647b2001953f, replyNumber=0, likeNumber=117, createdTime=2020-12-05, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=647b2001953f, moduleTitle=移植物抗宿主病（GVHD）新药开发攻略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=647b2001953f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655596, encodeId=29e8165559658, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=BMJ：公共财政支持与新药开发, objectType=article, longId=181996, objectId=5bea18199605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bea18199605, replyNumber=0, likeNumber=88, createdTime=2019-12-06, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bea18199605, moduleTitle=BMJ：公共财政支持与新药开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bea18199605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655595, encodeId=165e16555953a, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=逆转糖尿病并发症有望新型膳食补充剂助力新药开发！, objectType=article, longId=167991, objectId=778c16e99141, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=778c16e99141, replyNumber=0, likeNumber=79, createdTime=2019-11-12, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=778c16e99141, moduleTitle=逆转糖尿病并发症有望新型膳食补充剂助力新药开发！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=778c16e99141)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655594, encodeId=7c15165559497, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=i-CR体外药敏筛选技术平台，开拓肿瘤新药开发新思路, objectType=article, longId=152210, objectId=626d15221025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=626d15221025, replyNumber=0, likeNumber=83, createdTime=2019-03-05, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=626d15221025, moduleTitle=i-CR体外药敏筛选技术平台，开拓肿瘤新药开发新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=626d15221025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655593, encodeId=88311655593de, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=Per Med：眼部疾病新药开发个性化治疗, objectType=article, longId=140587, objectId=53ad14058e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ad14058e6f, replyNumber=0, likeNumber=91, createdTime=2018-10-23, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ad14058e6f, moduleTitle=Per Med：眼部疾病新药开发个性化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53ad14058e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655592, encodeId=2fa416555929a, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=美政府6年投资逾千亿美元推动新药开发, objectType=article, longId=129953, objectId=f43e1299534c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f43e1299534c, replyNumber=0, likeNumber=92, createdTime=2018-08-23, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f43e1299534c, moduleTitle=美政府6年投资逾千亿美元推动新药开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f43e1299534c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655591, encodeId=77f9165559118, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=Nature:上海中科院药物所新成果促进糖尿病新药开发, objectType=article, longId=125547, objectId=8ac812554e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ac812554e26, replyNumber=0, likeNumber=84, createdTime=2018-12-18, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ac812554e26, moduleTitle=Nature:上海中科院药物所新成果促进糖尿病新药开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ac812554e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655590, encodeId=10081655590d6, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=Science：中科院发表重要研究成果，为新药开发加速, objectType=article, longId=76626, objectId=951ae662645, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=951ae662645, replyNumber=0, likeNumber=91, createdTime=2016-12-03, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=951ae662645, moduleTitle=Science：中科院发表重要研究成果，为新药开发加速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=951ae662645)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655589, encodeId=74ce165558974, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=Nat Commun：新方法或可有效降低新药开发的成本, objectType=article, longId=75166, objectId=1e68e5166f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e68e5166f2, replyNumber=0, likeNumber=73, createdTime=2017-02-22, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e68e5166f2, moduleTitle=Nat Commun：新方法或可有效降低新药开发的成本, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e68e5166f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655588, encodeId=87ad165558828, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=【盘点】Nature等：DNA编码文库或推动制药公司新药开发新高度, objectType=article, longId=63860, objectId=923c6386047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=923c6386047, replyNumber=0, likeNumber=97, createdTime=2016-03-01, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=923c6386047, moduleTitle=【盘点】Nature等：DNA编码文库或推动制药公司新药开发新高度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=923c6386047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655586, encodeId=440c1655586f4, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=据表明，医药公司对中枢神经系统新药开发失去兴趣, objectType=article, longId=45403, objectId=28ef4540353, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ef4540353, replyNumber=0, likeNumber=90, createdTime=2015-05-24, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ef4540353, moduleTitle=据表明，医药公司对中枢神经系统新药开发失去兴趣, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ef4540353)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655587, encodeId=f556165558e49, content=<a href='/topic/show?id=09635863424' target=_blank style='color:#2F92EE;'>#新药开发#</a>, objectTitle=单抗新药开发公司信达生物获1亿美元C轮融资, objectType=article, longId=46826, objectId=1a12468266b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a12468266b, replyNumber=0, likeNumber=80, createdTime=2015-03-04, rootId=0, userName=huangshifeng, userId=193924741789, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a12468266b, moduleTitle=单抗新药开发公司信达生物获1亿美元C轮融资, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a12468266b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

新药开发

2020-05-29

病毒猎手 (审核中...)

前往app查看评论内容

#骨质疏松##新药开发##多肽药物#

Cell子刊：既能促骨形成又能抑骨吸收，研究发现抗骨质疏松药物新靶标！

2022-10-04

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

专注改良新药开发！清普生物成功获得近5000万元pre-A轮融资

2020-09-17

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

移植物抗宿主病（GVHD）新药开发攻略

2020-12-05

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

BMJ：公共财政支持与新药开发

2019-12-06

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

逆转糖尿病并发症有望新型膳食补充剂助力新药开发！

2019-11-12

智智灵药 (审核中...)

前往app查看评论内容

#新药开发#

i-CR体外药敏筛选技术平台，开拓肿瘤新药开发新思路

2019-03-05

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

Per Med：眼部疾病新药开发个性化治疗

2018-10-23

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

美政府6年投资逾千亿美元推动新药开发

2018-08-23

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

Nature:上海中科院药物所新成果促进糖尿病新药开发

2018-12-18

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

Science：中科院发表重要研究成果，为新药开发加速

2016-12-03

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

Nat Commun：新方法或可有效降低新药开发的成本

2017-02-22

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

【盘点】Nature等：DNA编码文库或推动制药公司新药开发新高度

2016-03-01

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

据表明，医药公司对中枢神经系统新药开发失去兴趣

2015-05-24

huangshifeng (审核中...)

前往app查看评论内容

#新药开发#

单抗新药开发公司信达生物获1亿美元C轮融资

2015-03-04

科室
- - 订阅+
  - 更多科室
工具
服务